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47 Abstract
48 STUDY QUESTION: What is the rate of natural conception leading to ongoing 
49 pregnancy or live birth over 6–12 months for infertile women of age ≥ 35 years?
50 SUMMARY ANSWER: Natural conception rates were still clinically relevant in 
51 women aged 35 years and above and were significantly higher in women with 
52 unexplained infertility compared to those with other diagnoses.
53 WHAT IS KNOWN ALREADY: In recent years, increasing numbers of women 
54 have attempted to conceive at a later age, resulting in a commensurate increase in the 
55 need for ART. However, there is a lack of data on natural fertility outcomes (i.e. no 
56 interventions) in women with increasing age.
57 STUDY DESIGN, SIZE, DURATION: A systematic review with individual patient 
58 data (IPD) meta-analysis was carried out. PubMed, Medline, Embase, the Cochrane 
59 Library, clinicaltrials.gov were searched until 1st July 2018 including search terms 
60 “fertility service”, “waiting list”, “treatment-independent”, “spontaneous conception”. 
61 Language restrictions were not imposed. 
62 PARTICIPANTS/MATERIALS, SETTING, METHODS: Inclusion criteria were 
63 studies (at least partly) reporting on infertile couples with female partner of age ≥ 35 
64 years who attended fertility services, underwent fertility work-up (e.g. history, semen 
65 analysis, tubal status, ovulation status) and were exposed to natural conception (e.g. 
66 independent of treatment such as IVF, ovulation induction, tubal surgery). Studies 
67 that exclusively studied only one infertility diagnosis, without including other women 
68 presenting to infertility services for other causes of infertility, were excluded. For 
69 studies that met the inclusion criteria, study authors were contacted to provide IPD, 
70 after which fertility outcomes for women of age ≥ 35 years were retrieved. Time to 
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71 pregnancy or live birth and the effect of increasing age on fertility outcomes after 
72 adjustment for other prognostic factors were analysed. Quality of studies was graded 
73 with the Newcastle Ottawa-Scale (non-randomised controlled trials (RCTs)) or the 
74 Cochrane Risk of Bias tool (for RCTs). 
75 MAIN RESULTS AND THE ROLE OF CHANCE: We included nine studies 
76 (seven cohort studies and two RCTs) (n=4379 women of at least age 35 years), with 
77 the observed composite primary outcome of ongoing pregnancy or live birth 
78 occurring in 429 women (9.8%) over a median follow-up of 5 months (25th to 75th 
79 percentile: 2.5-8.5 months). Studies were of moderate to high quality. The probability 
80 of natural conception significantly decreased with any diagnosis of infertility, when 
81 compared with unexplained infertility. We found non-linear effects of female age and 
82 duration of infertility on ongoing pregnancy and tabulated the predicted probabilities 
83 for unexplained infertile women aged 35 to 42 years with either primary or secondary 
84 infertility and with a duration of infertility from 1 to 6 years. For a 35-year-old 
85 woman with 2 years of primary unexplained infertility, the predicted probability of 
86 natural conception leading to ongoing pregnancy or live birth was 0.15 (95% CI 0.11-
87 0.19) after 6 months and 0.24 (95% CI 0.17–0.30) after 12 months. For a 42-year-old 
88 woman, this decreased to 0.08 (95% CI 0.04–0.11) after 6 months and 0.13 (95% CI 
89 0.07–0.18) after 12 months.
90 LIMITATIONS, REASONS FOR CAUTION: In the studies selected, there were 
91 different study designs, recruitment strategies in different centres, protocols and 
92 countries and different methods of assessment of infertility. Data was limited for 
93 women above the age of 40 years.
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94 WIDER IMPLICATIONS OF THE FINDINGS: Women attending fertility 
95 services should be encouraged to pursue natural conception while waiting for 
96 treatment to commence and after treatment if it is unsuccessful. Our results may aid in 
97 counseling women, and, in particular, for those with unexplained infertility.
98 STUDY FUNDING/COMPETING INTEREST(S):  SJC received funding from the 
99 University of Adelaide Summer Research Scholarship. BWM is supported by a 
100 NHMRC Practitioner Fellowship (GNT1082548).  The authors declare no conflict of 
101 interest except BWM who reports consultancy work for ObsEva, Merck Merck 
102 KGaA, iGenomix and Guerbet.
103 REGISTRATION NUMBER: CRD42018096552
104
105 Keywords: infertility, IVF, ART, waiting lists, time factors, maternal age, time-to-
106 pregnancy, middle-age, aging 
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108 Introduction
109 Sharp declines in fertility occur with increasing female age. These dramatic changes 
110 are generally in conjunction with a decreasing ovarian reserve. The mechanisms 
111 behind this deterioration in follicle number and quality, and menstrual cycle changes 
112 have yet to be precisely elucidated (Broekmans et al., 2009). In addition, there 
113 appears to be considerable natural variation in this decline in fertility, which has been 
114 shown to start at different female ages (De Brucker et al., 2013). 
115
116 Current trends in high-income societies indicate a postponement of childbearing in 
117 association with accessibility to contraception, economic prosperity, increased 
118 education and participation of women in the workforce (Leridon, 2006; Max Planck 
119 Institute for Demographic Research (Germany) and Vienna Institute of Demography 
120 (Austria), 2019). Such delays in childbearing naturally result in a heightened average 
121 age of first attempt at conception, a proportional increase in women above the age of 
122 30 years having their first child and higher failure rates of natural conception (Lutz et 
123 al., 2003). The follow-through effect can be observed in the disproportionate use of 
124 fertility services among older women (Adamson et al., 2018; Centers for Disease 
125 Control and Prevention, 2018; Fitzgerald O et al., 2019).
126
127 Along a similar vein, since the first successful IVF cycle for tubal infertility in 1978, 
128 indications for treatment have expanded to include women of advanced age with 
129 unexplained infertility (Adamson et al., 2018; Centers for Disease Control and 
130 Prevention, 2018; Fitzgerald O et al., 2019; Steptoe and Edwards, 1978). 
131 Controversies arise in the management of these women as IVF success rates are age-
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132 dependent, and the rate of maternal and foetal adverse events also escalates with 
133 increasing age (Adamson et al., 2018; Centers for Disease Control and Prevention, 
134 2018; Fitzgerald O et al., 2019). However, given the accelerated decline in fecundity 
135 in women over the age of 30 years, delaying ART in favour of pursuing natural 
136 conception may result in time-sensitive irreversible losses of ovarian reserve, which 
137 further jeopardizes fertility outcomes (Habbema et al., 2015). This is the dilemma of 
138 female age in managing infertile couples (Eshre Capri Workshop Group, 2017).
139
140 Data on natural fertility outcomes (i.e. no interventions) with increasing age is 
141 required in order to empower women to make informed choices when deciding on 
142 fertility treatments. The only available data at present is derived from historical non-
143 contraceptive natural fertility studies from the late 20th century and it is unknown 
144 whether such fertility outcomes are applicable to women of the 21st century 
145 (Eijkemans et al., 2014; Henry, 1965; Leridon, 1977). Individual-participant data 
146 (IPD) meta-analysis is a powerful modern tool allowing for the extraction, 
147 combination and analysis of data from clinical studies. Such an approach is suited to 
148 investigating natural fertility outcomes for women of older reproductive age since 
149 individual study datasets are generally too small to make accurate predictions for this 
150 subgroup of women.
151
152 We aimed to answer the following questions using IPD meta-analysis:
153  - What is the rate of natural conception leading to live birth over 6–12 months for 
154 infertile women of age ≥ 35 years?
155 - What are the factors affecting time to conception leading to livebirth?
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156 Materials and Methods
157 Criteria for considering studies in this review
158 Participants
159 IPD of studies reporting (fully or partially) on women aged ≥ 35 years attending 
160 fertility services. Subfertility was defined as “a disease characterized by the failure to 
161 establish a clinical pregnancy after 12 months of regular, unprotected sexual 
162 intercourse or due to an impairment of a person's capacity to reproduce either as an 
163 individual or with his/her partner” (Zegers-Hochschild et al., 2017).
164
165 Types of studies
166 The following study designs were eligible: case-control studies, cohort studies 
167 (prospective and retrospective) and randomised controlled trials (RCT).
168
169 Interventions
170 Studies reporting on fertility outcomes independent of ART (e.g. IVF, surgery, tubal 
171 catheterisation or ovulation induction) were included. These included women 
172 undergoing a diagnostic fertility work-up, women on a waiting list for treatment, or 
173 women who discontinued treatment. Studies on women undergoing non-artificial 
174 interventions (e.g. timed intercourse, lifestyle advice) were also eligible. Studies only 
175 reporting on fertility outcomes dependent on ART were excluded. Studies on women 
176 that have undergone interventions that have permanently altered their reproductive 
177 system (for example tubal surgery) were also excluded. 
178
179 Outcome measures
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180 The primary outcome measure was a composite of the cumulative rate of natural 
181 conceptions leading to ongoing pregnancy and the cumulative rate of natural 
182 conceptions leading to live birth. This is because live birth was not recorded for all 
183 women in all cohorts and, in absence, ongoing pregnancy was used. We refer to this 
184 composite outcome as (natural conception leading to) ongoing pregnancy.
185
186 Time to natural conception leading to ongoing pregnancy or live birth was calculated 
187 from the date of entry to the fertility service (for cohort studies) or date of 
188 randomisation (for RCTs) to last menstrual period when pregnancy occurred. If last 
189 menstrual period was not available, this was estimated with the assumption of term 
190 delivery at 40 weeks gestation. In order to extract the treatment-independent time to 
191 natural conception for all cohorts, women were censored at time of treatment, natural 
192 conception or end of follow-up, with censoring at whichever of these events occurred 
193 first. 
194
195 Ongoing pregnancy was defined as visualisation of foetal heartbeat by ultrasound 
196 after 20 weeks of gestation per woman. In studies defining ongoing pregnancy as a 
197 sonographic foetal heartbeat beyond 8 or 12 weeks, we used that definition. Live birth 
198 was defined as delivery of at least one live foetus after 20 weeks of gestation per 
199 woman. The occurrence of multiple pregnancies resulting in the birth of more than 
200 one baby was considered a single event. 
201
202 Other secondary outcomes were clinical pregnancy defined as pregnancy diagnosed 
203 by ultrasonographic visualisation of one or more gestational sacs or definitive clinical 
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204 signs of pregnancy, miscarriage defined as the spontaneous loss of an intra-uterine 
205 pregnancy prior to 22 completed weeks of gestational age, ectopic pregnancy defined 
206 as a pregnancy outside the uterine cavity diagnosed by ultrasound, surgical 
207 visualisation or histopathology, and chemical pregnancy defined as pregnancy 
208 diagnosed only by the detection of beta hCG in serum or urine (Zegers-Hochschild et 
209 al., 2017). 
210 The following other factors known to affect natural fertility were collected: diagnosis, 
211 duration of infertility, referral status, BMI, primary versus secondary infertility, 
212 semen characteristics (volume, morphology, motility, concentration), cycle length, 
213 basal FSH levels, antral follicle count, anti-Müllerian hormone (AMH), tubal status 
214 and semen status (Bensdorp et al., 2017). 
215 Data collection and analysis
216 Search strategy
217 The following databases were searched to 1.7.2018: PubMed, MEDLINE, EMBASE, 
218 Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled 
219 Trials (CENTRAL), the Cochrane Library, clinicaltrials.gov. Relevant reviews and 
220 references lists of included studies were hand searched. The search strategy was 
221 documented in accordance to the Preferred Reporting Items for Systematic Reviews 
222 and Meta-Analyses (PRISMA) statement. Search terms included “fertility service”, 
223 “waiting list”, “treatment-independent”, and “spontaneous conception”. Language 
224 restriction was not applied. Studies prior to the year 2000 were excluded on the basis 
225 that the original authors would likely no longer have access to IPD.
226
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227 Selection of studies
228 Two authors (SJC and NAD) independently assessed the included studies, in order to 
229 ascertain eligibility for inclusion, extract outcomes of interest and determine the 
230 quality of studies. In the event of discrepancies, a third author was introduced (BWM) 
231 to form a final decision.
232
233 Assessment of risk of bias
234 Two authors (SJC and NAD) independently assessed risk of bias of included studies 
235 using the following tools:
236 - The risk of bias assessment tool developed by the Cochrane Collaboration 
237 for RCTs (Higgins et al., 2011)
238 - The Newcastle-Ottawa Scale for cohort studies and case-control studies (GA 
239 Wells, 2008).




244 Corresponding authors of identified studies were contacted and invited to provide 
245 IPD. Study protocols were obtained. 
246
247 Analysis
248 All IPD for women aged ≥ 35 years were combined into a single database, including 
249 all available variables corresponding to studied outcomes (as above). We used a 
250 Kaplan-Meier curve to show the estimated cumulative natural conception rate per 
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251 infertility diagnosis group. Cox proportional hazards analysis was conducted to 
252 determine which factors were related to time-to-pregnancy for women aged ≥ 35 
253 years. Scaled Schoenfeld residuals were used to check if the estimated effect of 
254 covariates were proportional over time (Grambsch and Therneau, 1994). Restricted 
255 cubic spline analysis was used to assess whether there was a linear association 
256 between female age as a continuous variable and natural conception leading to 
257 ongoing pregnancy or live birth (Harrell, 2001). The best fit was preferred, judged by 
258 a Wald test for non-linear terms and the lowest Akaike Information Criterion (Akaike, 
259 2011). If fits were similar, the simplest model was preferred (i.e. the model with the 
260 lowest number of knots or parameters estimated).
261
262 In the case where a non-linear association was discovered, the effect of different 
263 female ages on live birth rates, ranging from 35 to 43 years, was visualised in a plot. 
264 Using the model with the best fit, absolute chances of natural conception over 6 and 
265 12 months were tabulated for all combinations of patient characteristics. 
266
267 Sensitivity analyses
268 Not all studies had collected data on all covariates, most notably FSH, AMH and 
269 semen parameters. Only when data was available from multiple studies, we 
270 considered these detailed covariates for analysis or to use in imputation. Otherwise 
271 analysis was restricted to covariates that were available in all studies. To account for 
272 the fact that we combined multiple studies using separate study designs, protocols and 
273 recruitment in different countries, we used a gamma frailty random effects Cox 
274 model. Using this model, we calculated the absolute chances of natural conception 
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275 over 6 or 12 months and presented these next to the tabulated chances from the Cox 
276 model without random effects.
277
278 Missing data




283 Data was prepared in SPSS Statistics (IBM, version 24, Armonk, NY, USA) and 
284 Microsoft Excel (Microsoft Office, version 15.41, Redmond, WA, USA), and 








293 The search strategy identified 3191 hits, of which 2224 were left after duplicates were 
294 removed (Supplementary Data). After study screening, 130 studies were deemed 
295 eligible, of which 28 were excluded as they were published prior to the year 2000. 
296 Emails were sent to authors of the remaining studies and authors of 30 studies replied, 
297 resulting in 18 unique databases. Upon receipt of the data, nine databases were 
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298 excluded. Two did not record natural conception outcome as they were from RCTs 
299 that only performed an intention-to-treat analysis without recording treatment-
300 independent pregnancies (Steiner et al., 2015), one database was a RCT embedded in 
301 a cohort yielding duplicate data (Custers et al., 2012), one database was in a file 
302 format that could not be accessed (Mol et al., 2001), and in seven, the treatment-free 
303 follow-up time could not be accurately ascertained (Brandes et al., 2009; Gnoth et al., 
304 2003; Osmanagaoglu et al., 2002; Walschaerts et al., 2012; Wynter et al., 2013). This 
305 resulted in nine included databases  (n=4,379 women). The number of women 
306 included and excluded based on study selection criteria was presented according to 
307 PRISMA guidance (Fig. 1). 
308
309 Of the included studies, two were RCTs and seven were cohort studies (six 
310 prospective, one retrospective). Of the RCTs, two investigated different contrast 
311 methods for hysterosalpingography (Dreyer et al., 2017; Lindborg et al., 2009). We 
312 included all arms, regardless of contrast used, in the meta-analysis as this was 
313 considered part of the diagnostic work-up). Of the cohort studies, one included 
314 women who discontinued ART (Cahill et al., 2005), one included women on the 
315 waiting list for ART (Eijkemans et al., 2008), and five included all women presenting 
316 for fertility services capturing all treatment-related and treatment-independent fertility 
317 outcomes during a fixed follow-up interval (Pearce et al., 2017; Pinborg et al., 2009; 
318 Rantsi et al., 2018; Righarts et al., 2017; van der Steeg et al., 2007).
319
320 Three studies were subgroup analyses from larger cohort studies or RCTs, where for 
321 the purposes of the meta-analysis the data from the original study was requested and 
Page 15 of 48
https://academic.oup.com/humrep
Draft Manuscript Submitted to Human Reproduction for Peer Review
15
322 the related publications were searched for (Pinborg et al., 2009; Rantsi et al., 2018; 
323 van der Steeg et al., 2007). Of note, based on local guidelines, some women with 
324 intermediate to good prognosis for natural fertility were preferentially counselled for 
325 initial expectant management (Eijkemans et al., 2008; Righarts et al., 2017; van der 
326 Steeg et al., 2007). Local guidelines and prognostic models used to calculate natural 
327 fertility were described, including the Hunault model (Hunault et al., 2004). Women 
328 of age ≥ 35 years were smaller subsets of the original studies, ranging from 29 to 
329 1445 (original study sizes ranged from 120 to 7860 participants).
330
331 Of the included studies, half were multicentre (four from the Netherlands, one from 
332 Denmark) (Dreyer et al., 2017; Eijkemans et al., 2008; Pinborg et al., 2009; van der 
333 Steeg et al., 2007), while the others were single centre studies. All studies originated 
334 from high-resourced countries. Six studies reported on live birth while three reported 
335 on pregnancy as the sole primary outcome (Eijkemans et al., 2008; Pearce et al., 
336 2017; van der Steeg et al., 2007). Data from these nine studies were used in the 
337 composite primary outcome of live birth and ongoing pregnancy. Definition of 
338 different subgroups of infertility was heterogeneous, including methods described by 
339 Hull, assessment according to the guidelines of the Dutch Society of Obstetrics and 
340 Gynaecology, local clinical priority access criteria (Dutch Society of Obstetrics and 
341 Gynaecology, 2004; Gillett et al., 2012; Hull et al., 1985) and was not described in 
342 two studies (Lindborg et al., 2009; Schmidt, 2006). 
343
344 Of the prognostic factors of interest, all studies with exception of one (Pearce et al., 
345 2017) reported duration of infertility, types of infertility and whether it was primary 
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346 or secondary infertility. Secondary outcomes were reported in four studies (Cahill et 
347 al., 2005; Dreyer et al., 2017; Lindborg et al., 2009; Pinborg et al., 2009), of which 
348 two studies reported on multiple pregnancy (Cahill et al., 2005; Dreyer et al., 2017), 
349 four reported on rate of miscarriage (Cahill et al., 2005; Dreyer et al., 2017; Lindborg 
350 et al., 2009; Schmidt, 2006) and two reported on the rate of ectopic pregnancy (Cahill 
351 et al., 2005; Dreyer et al., 2017). Ongoing pregnancy in these studies was defined as 
352 foetal cardiac activity on ultrasound on assessment, either at gestation of at least 8 
353 weeks (Eijkemans et al., 2008) or at least 12 weeks (van der Steeg et al., 2007). Data 
354 for ongoing pregnancy as defined by the protocol of at least 20 weeks could not be 
355 obtained. One study reported time to delivery, where time to conception was 
356 estimated with the assumption of term delivery (Righarts et al., 2017). 
357 Methodological characteristics of included studies are presented in table form (Table 
358 I). 
359
360 Studies were generally of moderate to high quality (Table II and Table III). Most 
361 cohort studies included all women presenting to fertility services with a follow-up of 
362 up to 13 years for some cohorts and were graded as high quality. This was particularly 
363 true for large cohort studies (Eijkemans et al., 2008; Righarts et al., 2017; van der 
364 Steeg et al., 2007). RCTs were of high quality with clear method of randomisation 
365 and allocation concealment. Given the objective outcomes livebirth or ongoing 
366 pregnancy, this was graded as unclear risk of bias despite lack of blinding. A funnel 
367 plot could not be used for the detection of publication bias as not all studies were 
368 powered to detect natural conception.
369
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370 IPD meta-analysis
371 Baseline characteristics of the women are in Table IV. A total of 4,379 women from 
372 six countries were included of whom median female age was 37.3 years (25th–75th 
373 percentile 36.1–38.9 years). There was little data (n=531) for women over 40 years. 
374 Median duration of infertility was 2.4 years (25th–75th percentile 1.5–4.0 years), of 
375 which 2,367 (54%) were primary infertility cases. Unexplained infertility accounted 
376 for the most infertility at 51.0% (n=2,233), followed by male factor (21.2%, n=930), 
377 tubal factor (15.2%, n=667), ovulatory disorders (3.8%, n=168), endometriosis (3.4%, 
378 n=151), immunological causes (1.3%, n=59) and other causes of infertility (3.9%, 
379 n=171). Only one study included detailed covariate data, such as AMH and FSH, and 
380 therefore, these covariates were not used (van der Steeg et al., 2007). BMI and 
381 smoking status were also reported in four studies (Lindborg et al., 2009; Rantsi et al., 
382 2018; Righarts et al., 2017; van der Steeg et al., 2007). Data on the most important 
383 factors aside from female age, duration of infertility and primary or secondary 
384 infertility, was missing in n=32 (0.7%) which was accounted for using single 
385 imputation. 
386
387 When considering the composite primary outcome of live birth and ongoing 
388 pregnancy, a total of 429 events were noted (9.8%). Any specific diagnosis of 
389 infertility was associated with a lower hazard ratio (HR) for natural conception 
390 leading to ongoing pregnancy or live birth compared to unexplained infertility, except 
391 for immunological infertility which did not reach statistical significance (HR 0.11 
392 [95% CI 0.01-1.65]). HRs for male factor (HR 0.30 [95% CI 0.21-0.43]), tubal factor 
393 (HR 0.42 [95% CI 0.30-0.60]), endometriosis (HR 0.36 [95% CI 0.17-0.76]) and 
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394 ovulation disorders (HR 0.409 [95% CI 0.21-0.76]) were significantly lower 
395 compared to unexplained infertility.  In all infertility subgroups, the probability of 
396 natural conception leading to ongoing pregnancy increased over follow up with the 
397 exception of immunological infertility (Fig. 2).  
398
399 Given the heterogeneity in method of diagnosis and the large availability of robust 
400 data for women with unexplained infertility, further analysis of the probability of 
401 ongoing pregnancy in these women (n=2,404) was performed. For women with 
402 unexplained infertility, the Kaplan-Meier estimate of natural conception leading to 
403 ongoing pregnancy or live birth was 13.3% (95% CI 11.7–14.9%) within 6 months 
404 and 21.9% (95% CI 19.2–24.5) within 12 months (Fig. 3).
405
406 The final Cox model contained female age, duration of infertility and primary or 
407 secondary infertility. In the analysis of those with unexplained infertility, the model 
408 with non-linear effects for female age and duration of infertility fitted best (using 
409 restricted cubic splines with 3 and 4 knots, respectively). The non-linear effect of 
410 female age on natural conception leading to ongoing pregnancy is shown  (Fig. 4), 
411 where the probability of natural conception decreases for women aged 38 years or 
412 older. Using this model, a 35-year-old woman with 2 years of primary unexplained 
413 infertility had a predicted probability of natural conception of 0.15 (95% CI 0.11-
414 0.19) after 6 months and 0.24 (95% CI 0.17–0.30) after 12 months (Table V). For a 
415 woman of age 42 years, this decreased to 0.08 (95% CI 0.04–0.11) after 6 months and 
416 0.13 (95% CI 0.07–0.18) after 12 months. For women with primary unexplained 
417 infertility who have been trying to conceive naturally for 5 years, there was very low 
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418 (<5%) probability of natural conception leading to ongoing pregnancy over 12 months 
419 when the woman is 41 years old or above (Table V). The results with the random 
420 effects Cox model were more optimistic, estimating higher probabilities of ongoing 
421 pregnancy than the Cox model without random effects, and never reaching below 5% 
422 over 12 months.
423
424 Three studies recorded time to treatment and treatment related outcomes (Rantsi et 
425 al., 2018; Righarts et al., 2017; Schmidt, 2006). Given the heterogeneity in types of 
426 treatment the women received, the different starting times of treatment after 
427 recruitment that does not allow a direct comparison and the relatively small numbers 




432 Summary of findings
433 This study was designed to guide treatment strategies for women of age ≥ 35 years 
434 presenting to a fertility service. As expected, natural fertility declined with female 
435 age. This association between female age and time to natural conception leading to 
436 ongoing pregnancy or live birth was non-linear. Studies were of moderate to high 
437 quality and mainly derived from high resource settings. Of note, any diagnosis of 
438 infertility conferred a poorer prognosis compared with unexplained infertility.
439
440
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441 Strengths and limitations
442 The IPD meta-analysis method was used to incorporate all available data on women 
443 aged 35 years or above to estimate more accurately their probability of a natural 
444 conception leading to ongoing pregnancy or live birth. The most important limitation 
445 in our study is the aggregation of studies that used different study design, recruitment 
446 strategies in different centres, protocols and countries. In addition, as this was an 
447 undifferentiated population of women, with heterogeneous methods used in defining 
448 tubal status, male infertility and ovulatory status, the most robust conclusions could 
449 only be made for those with unexplained infertility. Additionally, only one study 
450 reported on outcomes from immunological infertility (Eijkemans et al., 2008). The 
451 frailty model was utilised in order to account for these differences. This resulted in 
452 higher point estimates and undefined CIs, however did not change the relationship 
453 between age and time to natural conception. 
454
455 Limited confounding variables (diagnoses, duration of infertility and whether 
456 infertility was primary or secondary) were included in the analysis, however other 
457 known variables that could potentially impact on fertility (e.g. AMH, BMI) were 
458 insufficient. Additionally, data on secondary outcomes, such as multiple pregnancy 
459 and ectopic pregnancy, were negligible.
460
461 The effect of treatment was not an area of interest that was explored in this study. In 
462 order to provide the best model for clinical decision-making, we have elected to study 
463 only natural conception in the absence of treatment. This is because the effect of 
464 treatment would likely act as a competing risk, resulting in a reduction in detected 
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465 rates of natural conception. This was addressed by censoring women at the time when 
466 treatment occurred. However, due to this censorship, follow-up time was significantly 
467 truncated for many women included in this IPD analysis, as some would have 
468 commenced treatment at an earlier date before natural conception occurred.
469
470 The major contributors to our study came from Dutch data, in which some patients 
471 with intermediate to good prognosis for natural conception were preferentially 
472 counselled for expectant management, although this did not seem to introduce a 
473 strong confounding effect (van Geloven et al., 2014). Also, addition of the RCTs 
474 introduced strict inclusion and exclusion criteria, where severe male infertility and 
475 tubal pathology were excluded (Dreyer et al., 2017; Lindborg et al., 2009). 
476 Unfortunately, there was little data for women above the age of 40 years.
477
478 Clinical implications
479 Female age is a strong predictor of infertility, which also is reflected in the fact that 
480 increasing age predicts poorer outcomes for ART (Centers for Disease Control and 
481 Prevention, 2018; Fitzgerald O et al., 2019; Malchau et al., 2017). In addition, it is 
482 unclear whether ART adds any meaningful increase in live birth rate on top of natural 
483 fertility for certain diagnoses (McLernon et al., 2016; van Eekelen et al., 2019). 
484 Moreover, the costs and adverse effects, such as multiple live birth rate, warrant 
485 objective evaluation of ART use/recommendations.
486
487 On a global scale, older women account for a significant proportion of ART usage. In 
488 2011, a study incorporating 2,560 centres from 65 countries discovered that women 
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489 who were at least 35 years old accounted for 60% of ART usage (Adamson et al., 
490 2018). In 2016, this percentage remained stable at 61–62% in women from high 
491 resource settings (Centers for Disease Control and Prevention, 2018; Fitzgerald O et 
492 al., 2019). Treatment decisions are also influenced by reimbursement policies, which 
493 may impose age restrictions. In addition, there have been no RCTs investigating 
494 treatment versus no treatment in a cohort of this age. Existing data tends to report per 
495 cycle outcomes and do not take into account the dropout rate of women attending 
496 fertility services, which may skew fertility outcomes.
497
498 Women attending fertility services should be encouraged to pursue natural conception 
499 while waiting for treatment commencement, as well as during treatment, and not give 
500 up on their fertility even after treatment fails (Walschaerts et al., 2012; Wynter et al., 
501 2013). Women of advanced maternal age with low natural fertility chances as well as 
502 low chances from treatment could potentially be counselled for donor oocyte 
503 treatment (Hogan et al., 2019). Clearly, natural fertility remains an important source 
504 of live birth and ongoing pregnancy, and should not be neglected in the context of 
505 clinical counselling and research, especially for women with unexplained infertility.
506
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729  Figure 1 PRISMA individual participant data flow diagram.
730 PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses, 
731 IPD: individual participant data
732
733 Figure 2 Kaplan-Meier curves depicting the natural rate of conception leading to 
734 ongoing pregnancy or live birth, stratified for the different types of infertility.
735
736 Figure 3 Kaplan-Meier curve depicting the natural rate of conception leading to 
737 ongoing pregnancy or live birth for unexplained infertile couples or unknown 
738 diagnoses. 
739 Dotted lines are 95% confidence limits.
740
741 Figure 4 Effect of female age on the probability of natural conception leading to 
742 ongoing pregnancy or live birth within 12 months. 
743 Grey areas indicate 95% confidence limits.
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Figure 1
3190 studies identified through database 
searching
1 study identified through other sources including 
contact with researchers
2224 studies after duplicates removed 
2224 studies screened for eligibility 
2094 studies excluded 
352 study design; 1051 intervention; 3 <35yo; 6 Low 
sample size; 99 Not human; 345 Not infertile; 24 Not 
fertility outcomes; 214 known diagnoses
102 studies for which IPD were sought 28 eligible Studies for which IPD were not sought 
(published prior to 2000) 
30 studies for which IPD were provided (18 unique 
cohorts) 
9 cohorts excluded (2 natural conception not 
recorded; 1 data not in accessible format; 1 duplicate 
study; 5 unclear time to pregnancy)
72 studies for which IPD were not provided 
6 no access to data; 8 email addresses not in use; 2 
emails could not be located; 2 sample size too small; 
54 nil response from authors
Number of participants
Reasons for not providing IPD should be stated
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Figure II. Kaplan-Meier curves depicting the natural rate of conception leading to ongoing pregnancy or 
livebirth, stratified for the different types of infertility 
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Figure III. Kaplan-Meier curve depicting the natural rate of conception leading to ongoing pregnancy or 
livebirth for unexplained infertile couples or unknown diagnoses. 
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Figure IV. Effect of female age on the probability of natural conception leading to ongoing pregnancy or 
livebirth within 12 months 
198x152mm (300 x 300 DPI) 
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Table I Study and methodological characteristics.
Study design Setting Inclusion criteria Exclusion criteria Outcomes of 
interest
Prognostic factors
Livebirth Duration infertileSevere male factor
Multiple pregnancy Diagnoses
Ectopic pregnancy











Duration infertileSevere male factor 
Diagnoses
Primary/Secondary













(US ≥ 12 weeks)
Sperm, FSH
Endocrine disorder Livebirth Duration infertile
Severe male factor Multiple pregnancy Diagnoses
Severe tubal factor Ectopic pregnancy






Age 8-39 years, 
spontaneous menstrual 
cycles, infertile at least 1 
year, indication for 












All couples who attended 
for IVF
Non-IVF treatment Ongoing pregnancy 




















Severe tubal factor Primary/Secondary
Lindborg et al. 
(n=66)
RCT Single centre 
(Finland), 2001-
2006






Pearce et al. Retrospective Single centre All couples who attended Pregnancy Diagnoses
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All couples who attended 
for fertility treatment 
Miscarriage
Primary/Secondary
HyCoSy: hysterosalpingography,  US: ultrasound, RCT: randomised controlled trial
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1 2 3 4 1 1 2 3
Cahill et al. * *  * *  *  
Eijkemans et al. * * * * * * * *
Righarts et al. * * * * * * * *
Van der Steeg et al. * * * * * * * *
Pearce et al.  * *  *  * *
Pinborg et al. * *    *  
Rantsi et al. * * * * * * * *
Table III Risk of bias grading of randomised controlled trials utilising the Cochrane Risk of Bias tool.
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Table IV Characteristics of all included couples by cohort. 
Eijkemans et 
al.








Cahill et al. Rantsi et al. Pearce et al.
n=1802 n=1445 n=356 n=312 n=262 n=66 n=66 n=41 n=29

























3.2 [2.1, 4.7] 1.6 [1.2, 2.5] 2.9 [1.6, 
5.0]
1.8 [1.3, 2.3] 4.0 [3.0, 5.0] 2.0 [1.5-2.5] 5.0 [3.0, 7.0] 1.5 [1.0, 3.0] 8.0 [3.0-
11.0]
Primary infertile (%) 944 (52.4) 772 (53.4) 230 (64.6) 182 (58.3) 135 (51.5) 27 (40.9) 43 (65.2) 17 (41.5)  20 (69)
Median follow up, 
in months




462 (25.6) 1207 (83.5) 86 (24.2)  275 (88.1) 83 (31.7) 66 (100) 9 (14.3) 19 (46.3) 26 (89.7)
Male factor (%) 581 (32.2) 142 (9.8)  114 (32.0) - 74 (28.2) - 16 (25.4) 3 (7.3) -
Tubal factor (%) 373 (20.7) 96 (6.6)  76 (21.3) 25 (8.0) 64 (24.4)  - 23 (36.5) 8 (19.5) 2 (6.9)
Endometriosis (%) 106 (5.9) - 29 (8.1) - - - 9 (14.3)  6 (14.6) 1 (3.4)
Hormonal/menstru
al cycle infertility 
(%)
109 (6.0) - 38 (10.7) - 17 (6.5) - - 4 (9.8) -
Immunological 
infertility (%)
59 (3.3) - - - - - - - -
Uncertain/other (%) 112 (6.2) - 13 (3.7)   12 (3.8) 24 (9.2) - 6 (9.5) 1 (2.4) -
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Table V Predicted probabilities of natural conception over 6 or 12 months for couples with unexplained infertility for various combinations of female age, 









over 6 months (95%CI)
Predicted probability 
over 12 months (95%CI)
*Predicted probability 
over 6 months  (frailty)
*Predicted probability 
over 12 months (frailty)
35 1 Primary 0.18 (0.12 - 0.24) 0.29 (0.20 - 0.37) 0.23 0.37
36 1 Primary 0.19 (0.14 - 0.23) 0.30 (0.23 - 0.36) 0.24 0.38
37 1 Primary 0.19 (0.14 - 0.23) 0.30 (0.23 - 0.36) 0.24 0.38
38 1 Primary 0.17 (0.13 - 0.22) 0.28 (0.21 - 0.34) 0.23 0.36
39 1 Primary 0.15 (0.11 - 0.19) 0.25 (0.19 - 0.31) 0.20 0.32
40 1 Primary 0.13 (0.09 - 0.17) 0.22 (0.16 - 0.27) 0.17 0.28
41 1 Primary 0.11 (0.07 - 0.15) 0.18 (0.12 - 0.24) 0.14 0.23
42 1 Primary 0.09 (0.05 - 0.13) 0.15 (0.09 - 0.22) 0.12 0.20
35 2 Primary 0.15 (0.11 - 0.19) 0.24 (0.17 - 0.30) 0.18 0.29
36 2 Primary 0.15 (0.12 - 0.18) 0.25 (0.19 - 0.29) 0.18 0.30
37 2 Primary 0.15 (0.12 - 0.18) 0.25 (0.19 - 0.29) 0.18 0.30
38 2 Primary 0.14 (0.11 - 0.17) 0.23 (0.18 - 0.28) 0.17 0.28
39 2 Primary 0.13 (0.10 - 0.16) 0.21 (0.16 - 0.25) 0.15 0.25
40 2 Primary 0.11 (0.08 - 0.14) 0.18 (0.13 - 0.22) 0.13 0.21
41 2 Primary 0.09 (0.06 - 0.12) 0.15 (0.10 - 0.20) 0.11 0.18
42 2 Primary 0.08 (0.04 - 0.11) 0.13 (0.07 - 0.18) 0.09 0.15
35 3 Primary 0.08 (0.06 - 0.11) 0.14 (0.09 - 0.18) 0.11 0.18
36 3 Primary 0.09 (0.06 - 0.11) 0.14 (0.11 - 0.17) 0.11 0.19
37 3 Primary 0.08 (0.06 - 0.11) 0.14 (0.11 - 0.17) 0.11 0.19
38 3 Primary 0.08 (0.06 - 0.10) 0.13 (0.10 - 0.17) 0.10 0.18
39 3 Primary 0.07 (0.05 - 0.09) 0.12 (0.09 - 0.15) 0.09 0.16
40 3 Primary 0.06 (0.04 - 0.08) 0.10 (0.07 - 0.13) 0.08 0.13
41 3 Primary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.06 0.11
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42 3 Primary 0.04 (0.02 - 0.06) 0.07 (0.04 - 0.10) 0.05 0.09
35 4 Primary 0.06 (0.03 - 0.08) 0.09 (0.06 - 0.13) 0.08 0.13
36 4 Primary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.13) 0.08 0.14
37 4 Primary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.13) 0.08 0.14
38 4 Primary 0.05 (0.04 - 0.07) 0.09 (0.06 - 0.12) 0.07 0.13
39 4 Primary 0.05 (0.03 - 0.06) 0.08 (0.05 - 0.11) 0.06 0.11
40 4 Primary 0.04 (0.02 - 0.05) 0.07 (0.04 - 0.09) 0.05 0.09
41 4 Primary 0.03 (0.02 - 0.05) 0.06 (0.03 - 0.08) 0.04 0.08
42 4 Primary 0.03 (0.01 - 0.04) 0.05 (0.02 - 0.07) 0.04 0.06
35 5 Primary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.07 0.11
36 5 Primary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.07 0.12
37 5 Primary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.07 0.12
38 5 Primary 0.05 (0.03 - 0.06) 0.08 (0.05 - 0.10) 0.06 0.11
39 5 Primary 0.04 (0.02 - 0.05) 0.07 (0.04 - 0.09) 0.06 0.09
40 5 Primary 0.03 (0.02 - 0.05) 0.06 (0.03 - 0.08) 0.05 0.08
41 5 Primary 0.03 (0.02 - 0.04) 0.05 (0.03 - 0.07) 0.04 0.07
42 5 Primary 0.02 (0.01 - 0.04) 0.04 (0.02 - 0.06) 0.03 0.05
35 6 Primary 0.05 (0.03 - 0.07) 0.08 (0.04 - 0.11) 0.06 0.11
36 6 Primary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.06 0.11
37 6 Primary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.06 0.11
38 6 Primary 0.04 (0.03 - 0.06) 0.07 (0.05 - 0.10) 0.06 0.10
39 6 Primary 0.04 (0.02 - 0.05) 0.07 (0.04 - 0.09) 0.05 0.09
40 6 Primary 0.03 (0.02 - 0.05) 0.06 (0.03 - 0.08) 0.04 0.08
41 6 Primary 0.03 (0.01 - 0.04) 0.05 (0.02 - 0.07) 0.04 0.06
42 6 Primary 0.02 (0.01 - 0.03) 0.04 (0.02 - 0.06) 0.03 0.05
35 1 Secondary 0.22 (0.15 - 0.29) 0.35 (0.25 - 0.44) 0.28 0.44
36 1 Secondary 0.23 (0.17 - 0.28) 0.36 (0.28 - 0.43) 0.29 0.45
37 1 Secondary 0.23 (0.18 - 0.28) 0.36 (0.28 - 0.43) 0.29 0.45
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38 1 Secondary 0.22 (0.16 - 0.26) 0.34 (0.26 - 0.41) 0.28 0.43
39 1 Secondary 0.19 (0.15 - 0.23) 0.30 (0.24 - 0.37) 0.24 0.38
40 1 Secondary 0.16 (0.12 - 0.20) 0.26 (0.20 - 0.32) 0.21 0.33
41 1 Secondary 0.14 (0.09 - 0.18) 0.22 (0.15 - 0.29) 0.17 0.28
42 1 Secondary 0.12 (0.07 - 0.16) 0.19 (0.11 - 0.26) 0.14 0.24
35 2 Secondary 0.18 (0.13 - 0.23) 0.29 (0.21 - 0.37) 0.22 0.35
36 2 Secondary 0.19 (0.15 - 0.23) 0.30 (0.24 - 0.36) 0.23 0.36
37 2 Secondary 0.19 (0.15 - 0.23) 0.30 (0.24 - 0.36) 0.23 0.36
38 2 Secondary 0.18 (0.14 - 0.21) 0.28 (0.22 - 0.34) 0.21 0.34
39 2 Secondary 0.16 (0.12 - 0.19) 0.25 (0.19 - 0.31) 0.19 0.30
40 2 Secondary 0.13 (0.10 - 0.17) 0.22 (0.16 - 0.27) 0.16 0.26
41 2 Secondary 0.11 (0.07 - 0.15) 0.18 (0.12 - 0.24) 0.13 0.22
42 2 Secondary 0.09 (0.05 - 0.13) 0.15 (0.09 - 0.22) 0.11 0.18
35 3 Secondary 0.10 (0.07 - 0.13) 0.17 (0.12 - 0.22) 0.14 0.23
36 3 Secondary 0.11 (0.08 - 0.13) 0.17 (0.13 - 0.21) 0.14 0.23
37 3 Secondary 0.11 (0.08 - 0.13) 0.17 (0.13 - 0.21) 0.14 0.23
38 3 Secondary 0.10 (0.07 - 0.12) 0.16 (0.12 - 0.20) 0.13 0.22
39 3 Secondary 0.09 (0.06 - 0.11) 0.15 (0.11 - 0.18) 0.11 0.19
40 3 Secondary 0.07 (0.05 - 0.09) 0.12 (0.09 - 0.16) 0.10 0.16
41 3 Secondary 0.06 (0.04 - 0.08) 0.10 (0.07 - 0.14) 0.08 0.14
42 3 Secondary 0.05 (0.03 - 0.07) 0.09 (0.05 - 0.12) 0.07 0.11
35 4 Secondary 0.07 (0.04 - 0.10) 0.12 (0.07 - 0.16) 0.10 0.16
36 4 Secondary 0.07 (0.05 - 0.10) 0.12 (0.08 - 0.16) 0.10 0.17
37 4 Secondary 0.07 (0.05 - 0.10) 0.12 (0.08 - 0.16) 0.10 0.17
38 4 Secondary 0.07 (0.04 - 0.09) 0.11 (0.07 - 0.15) 0.09 0.16
39 4 Secondary 0.06 (0.04 - 0.08) 0.10 (0.07 - 0.13) 0.08 0.14
40 4 Secondary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.07 0.12
41 4 Secondary 0.04 (0.02 - 0.06) 0.07 (0.04 - 0.10) 0.06 0.10
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42 4 Secondary 0.03 (0.02 - 0.05) 0.06 (0.03 - 0.09) 0.05 0.08
35 5 Secondary 0.06 (0.03 - 0.08) 0.10 (0.06 - 0.14) 0.08 0.14
36 5 Secondary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.14) 0.08 0.14
37 5 Secondary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.14) 0.08 0.14
38 5 Secondary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.13) 0.08 0.14
39 5 Secondary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.07 0.12
40 5 Secondary 0.04 (0.03 - 0.06) 0.07 (0.04 - 0.10) 0.06 0.10
41 5 Secondary 0.04 (0.02 - 0.05) 0.06 (0.03 - 0.09) 0.05 0.08
42 5 Secondary 0.03 (0.01 - 0.04) 0.05 (0.02 - 0.08) 0.04 0.07
35 6 Secondary 0.06 (0.03 - 0.08) 0.10 (0.05 - 0.14) 0.08 0.14
36 6 Secondary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.14) 0.08 0.14
37 6 Secondary 0.06 (0.04 - 0.08) 0.10 (0.06 - 0.14) 0.08 0.14
38 6 Secondary 0.06 (0.03 - 0.08) 0.09 (0.06 - 0.13) 0.08 0.13
39 6 Secondary 0.05 (0.03 - 0.07) 0.08 (0.05 - 0.11) 0.07 0.11
40 6 Secondary 0.04 (0.02 - 0.06) 0.07 (0.04 - 0.10) 0.06 0.09
41 6 Secondary 0.03 (0.02 - 0.05) 0.06 (0.03 - 0.08) 0.04 0.08
42 6 Secondary 0.03 (0.01 - 0.04) 0.05 (0.02 - 0.07) 0.04 0.06
*The final two columns are average predictions from the Cox model including a random effect (frailty) for cohort. Note that the confidence limits of the 
latter are undefined.
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OR (fertility adj3 
service*).tw. 





OR (in vitro 
fertili?ation) .tw. 
OR (IVF).tw.) AND 




adj5 pregnan*) .tw. 
OR (spontaneous 
adj5 conception*).tw. 
OR (interval adj5 
pregnan*).tw. 
OR (interval adj5 
conception) .tw. 
OR (interval adj5 
conceptions) .tw. 
OR (natural* adj5 
conception*).tw. 
OR (natural* adj5 
pregnan*).tw. 
OR (conceive* adj5 
spontaneous*) .tw.




OR (livebirth adj5 
rate*) .tw. 
OR (birth adj5 rate*) 
.tw. 
OR (delivery adj5 
rate*) .tw. 
OR (fertili?ation adj5 
rate*) .tw. 
(female .tw.  OR wom?n*.tw. OR exp Women's Health/) AND (((Fertility adj3 clinic*) .tw.  OR 
(fertility adj3 service*).tw.  OR exp infertility therapy/ OR (Assisted reproductive tech*).tw.  
OR (in vitro fertili?ation) .tw.  OR (IVF).tw.) AND    ((waiting list*) .tw.  OR (treatment-
independent) .tw. OR (spontaneous* adj5 pregnan*) .tw. OR (spontaneous adj5 
conception*).tw.  OR (interval adj5 pregnan*).tw.  OR (interval adj5 conception) .tw.  OR 
(interval adj5 conceptions) .tw.  OR (natural* adj5 conception*).tw.  OR (natural* adj5 
pregnan*).tw.  OR (conceive* adj5 spontaneous*) .tw.  OR (conceive* adj5 natural*).tw.)) AND 
((Pregnan* adj5 rate*).tw.  OR (livebirth adj5 rate*) .tw.  OR (birth adj5 rate*) .tw.  OR 
(delivery adj5 rate*) .tw.  OR (fertili?ation adj5 rate*) .tw. )
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OR (birth rate)  
OR (delivery 
rate)  
OR (fertilisation  
rate)  
(female OR women) AND (((Fertility clinic) OR (fertility service) OR (Assisted Reproductive 
Technique) OR (Assisted Reproductive Technology)  OR (in vitro fertilisation) OR (IVF)) 
AND    ((waiting list) OR (treatment independent)  OR (spontaneous pregnancy) OR 
(spontaneous conception)  OR (interval pregnancy) OR (interval conception)  OR (interval 
conceptions) OR (natural conception)  OR (natural pregnancy)  OR (conceive spontaneous)   
OR (conceive natural))) AND ((Pregnancy rate)  OR (livebirth rate) OR (birth rate)  OR 
(delivery rate)   OR (fertilisation  rate))
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((Fertility clinic*)  
OR (fertility 
service*) 
OR (in vitro 
fertilisation)  
OR (IVF)) AND 










(((Fertility clinic*)   OR (fertility service*)  OR (in vitro fertilisation)   OR (IVF)) AND    
((waiting list)   OR (treatment independent) OR ((spontaneous* OR interval OR natural*) 
AND (conception* OR conceive* OR pregnan*)))) 
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